Hector Rosario Reyes, MD
Gynecology · Caguas, PRNPI 1023077575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Merck at 29.1% of the total. Reporting peaked in 2019 at $625 and has fallen 82.4% since, to $110 in 2025.
Across 40 payments — averaging $40.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$471
- AbbVie$192
- PBG Puerto Rico LLC$189
- Hologic Sales And Service, LLC$185
- BD$151
- Gen-probe Sales & Service, Inc.$124
- plus $308 from 5 others
What the payments were for
- Food & beverage$1,57998%
- Gifts$402%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 6 | $471 |
| AbbVie | 5 | $192 |
| PBG Puerto Rico LLC | 11 | $189 |
| Hologic Sales And Service, LLC | 6 | $185 |
| BD | 3 | $151 |
| Gen-probe Sales & Service, Inc. | 1 | $124 |
| Roche Diagnostics Corporation | 3 | $116 |
| Johnson And Johnson International | 1 | $100 |
| Ascend Therapeutics US, LLC | 2 | $40 |
| Exelixis Inc. | 1 | $31 |
| Pfizer Pharmaceuticals LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aptima$124
- Humira$120
- ENSEAL Product Family$100
How this compares
$1,619 in reported general payments places this provider in the 80th percentile of 50 gynecology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 73 | $27,209 |
| Estradiol | 61 | $5,407 |
| Clobetasol Propionate | 72 | $2,263 |
| Metronidazole | 27 | $1,601 |
| Estradiol (Once Weekly)Estradiol | 17 | $1,216 |
| Terconazole | 29 | $1,027 |
| Raloxifene Hcl | 13 | $732 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 34 | $469 |
| Fluconazole | 40 | $409 |
| ProgesteroneProgesterone, Micronized | 12 | $396 |
| Alendronate Sodium | 33 | $197 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $178 |
| Ciprofloxacin Hcl | 17 | $121 |
| ValacyclovirValacyclovir Hcl | 11 | $99 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $87 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Caguas
- Jose CruzCaguas$1K
- Ivan del Toro MartiCaguas$666
- Maria Roman LopezCaguas$258
- Rafael Alonso GodinezCaguas$147
- Juan Salgado MoralesSan Juan$39K
- Yolianne Lozada CaprilesSan Juan$9K
- Henry Rodriguez GinorioSan Juan$9K
- Luis FloresMayaguez$4K
- Jorge NegronSan Juan$3K
- Dalia Hernandez MedinaSan Juan$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.